The Cancer Letter

Inside information on cancer research and drug development

Vol.
30
No.
46
December 10, 2004Dec 10, 2004
Free
DOWNLOAD THE PDF

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

Also NCI prostate SPOREs plan biospecimen bank.

NCI advisors seek comment on clinical trials system, until Jan. 15.

NCI funds 17 EDRN biomarker labs. Bush signs omnibus funding legislation.

Dept. of Defense opens program announcements for prostate cancer research.

Children’s Cancer Research Institute at UT Health Science Center recruits faculty.

Two cancer center directors named: Michael Kastan at St. Jude, James Willson at Harold Simmons.

December issue of Business & Regulatory Report included (an additional 8 pages of industry news).

Next issue of The Cancer Letter is scheduled for Jan. 7, 2005.

Login

Looking for IP Login?